Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis

Gabriel Barsotti, Madhav C. Menon, Elizabeth Peck et al.|Kidney International Reports|2024

Cited by 3